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Abstract Components of the fibrinolytic system are subjected to stringent control to maintain proper hemostasis.
Central to this regulation is the serpin plasminogen activator
inhibitor-1 (PAI-1), which is responsible for specific and
rapid inhibition of fibrinolytic proteases. Active PAI-1 is
inherently unstable and readily converts to a latent, inactive
form. The binding of vitronectin and other ligands influences stability of active PAI-1. Our laboratory recently
observed reciprocal effects on the stability of active PAI-1
in the presence of transition metals, such as copper, depending on the whether vitronectin was also present (Thompson
et al. Protein Sci 20:353–365, 2011). To better understand
the molecular basis for these copper effects on PAI-1, we
have developed a gel-based copper sensitivity assay that can
be used to assess the copper concentrations that accelerate
the conversion of active PAI-1 to a latent form. The copper sensitivity of wild-type PAI-1 was compared with variants lacking N-terminal histidine residues hypothesized to
be involved in copper binding. In these PAI-1 variants, we
observed significant differences in copper sensitivity, and
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these data were corroborated by latency conversion kinetics
and thermodynamics of copper binding by isothermal titration calorimetry. These studies identified a copper-binding
site involving histidines at positions 2 and 3 that confers a
remarkable stabilization of PAI-1 beyond what is observed
with vitronectin alone. A second site, independent from
the two histidines, binds metal and increases the rate of the
latency conversion.
Keywords Protein structure · Calorimetry · PAI-1 ·
Vitronectin · Somatomedin B domain · Copper
Abbreviations
HDX	Hydrogen–deuterium
exchange
HDX-MS	Hydrogen–deuterium
exchange coupled to mass
spectrometry
IMAC	Immobilized metal affinity
chromatography
IPTG	Isopropyl
β-d-1-thiogalactopyranoside
ITC	Isothermal titration
calorimetry
H2A, H3A, and
H2AH3A-PAI-1	Mutant form of PAI-1 lacking N-terminal histidines at
positions 2, 3, or 2 and 3 in
the amino acid sequence,
respectively
RCL	Reactive center loop
SMB	Somatomedin B domain
PAs	Plasminogen activators
tPA	Tissue-type plasminogen
activator
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uPA	Urokinase plasminogen
activator
VN	Vitronectin
PAI-1	Plasminogen activator
inhibitor-1
Serpin	Serine protease inhibitor

Introduction
Plasminogen activator inhibitor-1 (PAI-1) is a serine protease inhibitor (serpin) responsible for controlling blood
flow, and thus is subjected to strict regulation at the genetic
as well as protein level [1]. PAI-1 inhibits tissue-type (tPA)
and urokinase (uPA) plasminogen activators (PAs) [1]. Inhibition of the PAs limits the amount of activated plasmin at a
site of injury or within the extracellular compartments, and
in turn controls physiological processes including hemostasis [2], extracellular matrix turnover [3], and cell adhesive/
migratory properties [4, 5]. Removal of PAI-1 results in
compromised wound healing and mild bleeding states due to
lack of control of the fibrinolytic components [6, 7], At the
same time, excessive levels of PAI-1 result in atherosclerosis
[8], fibrosis in several tissue types [9], inflammation [10],
metabolic syndrome [11], and cancer [12].
PAI-1 utilizes a solvent-exposed loop characteristic
of serpins termed the reactive center loop (RCL) shown
in Fig. 1 [13]. The RCL contains the same scissile bond
that the PAs target in their natural substrate, plasminogen [13]. The inhibitory mechanism of PAI-1 mirrors
the process of peptide bond cleavage by serine proteases
until the final step, in which the acylated RCL inserts into
the protein body, translocating the protease with a highly
distorted active site to the opposite pole of the inhibitor
[14]. Among serpins, PAI-1 is unique due to its inherent
metastability in the active form [15]. PAI-1 has a half-life
of approximately 1–2 h, then spontaneously undergoes a
significant structural rearrangement to an inactive, latent
form that can no longer inhibit proteases (Fig. 1) [16]. A
directed sequence of steps accounts for this conversion to
the latent structure, in which the uncleaved RCL must pass
through the gate region loops (s3C-s4C, s3B-hG) before
inserting in between the shutter region strands (s3A and
s5A) [17–19]. For full RCL peptide insertion to occur,
helix F (hF) covering the lower part of the shutter must be
temporarily displaced [20]. An area denoted the flexible
joint region (hD, hE, s1A) is important for protein–protein
interactions, most notably with another glycoprotein, vitronectin (VN) [21]. VN binds to PAI-1 with high affinity
(Kd ~0.1 nM) to localize and stabilize PAI-1 in the active
form [22, 23].

13

Fig. 1  PAI-1 exists in an active and latent conformation. The structure of the active form of plasminogen activator inhibitor-1 (PAI1) (PDB entry 3Q02) and the latent form of PAI-1 (PDB entry
1DVN) are shown. The reactive center loop (RCL) (red) acts as
bait for proteases in the active form where it is solvent-exposed;
it is inserted into central β-sheet A in the latent form. Several steps
in the mechanism of the transition to the latent form have been proposed [31], and it appears that local unfolding within key regions is
involved [30]. The shutter region (teal) expands, and the gate region
loops (blue) rearrange during the RCL insertion that occurs during
the latency conversion. Helix F (purple) may be displaced temporarily during unfolding of the hydrophobic core and/or rearrangement in
the bottom half of the shutter when the RCL is added as an additional
strand in the central β-sheet. The flexible joint region (green) is an
important site for PAI-1 protein–protein interactions, including binding of the somatomedin B (SMB) domain [22]. The nomenclature
for secondary structure is as follows: hA − hI are α-helices A − I,
respectively; s1A is strand 1 of β-sheet A, s6B is strand 6 of β-sheet
B, etc. The structure and location of histidines 2 and 3 are shown in
orange for each view of the active or latent form of PAI-1

Several factors influence the rate at which PAI-1
converts to the latent form, including ligands [24, 25],
post-translational modifications [26], pH [27], and protein dynamics [28, 29]. Protein dynamics play a role in
the latency process, whereby conditions that stabilize
PAI-1 decrease protein dynamics, and those that destabilize PAI-1 increase protein dynamics [29]. Furthermore,
hydrogen–deuterium exchange mass spectrometry (HDXMS) has revealed local unfolding events within the hydrophobic core of PAI-1 that are hypothesized to be on the
path to the latent state [30]. Ligands such as VN [24],
antibodies [31], and RNA aptamers [25] stabilize PAI-1 to
varying degrees; these ligands also restrict PAI-1 dynamics [28, 32].
Metal ion ligands such as copper have a particularly interesting effect on the stability of PAI-1, observed in its rate
of latency conversion in the presence and absence of VN,
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as well as the isolated N-terminal somatomedin B (SMB)
domain [28]. Copper binds to PAI-1 with high affinity (Kd
~0.09 μM), resulting in significant acceleration in the rate
of latency conversion [33]. However, when bound to both
VN (or the isolated SMB domain) and copper, PAI-1 is stabilized to an even greater extent than observed upon binding
of VN or SMB alone [24]. These unusual metal effects have
not been observed with any other serpins. HDX-MS experiments determined that addition of copper destabilizes PAI-1
by localized increases in protein dynamics [29], whereas the
combination of copper and SMB binding results in decreases
in dynamics within the same regions of PAI-1 [29].
Several parallels can be drawn comparing disease states
due to dysregulation of PAI-1 and those due to copper
homeostasis. Physiological copper concentrations are under
stringent temporal and spatial control within and outside
cells. Copper is a required cofactor for the function of many
proteins, but in excess is highly toxic [34, 35]. Copper is
integral to wound healing and angiogenesis, as its removal
retards both processes [36]. Copper is known to be involved
in vascular permeability, platelet–endothelial interactions,
and the activation of smooth muscle cells [37]. On the other
hand, elevated levels of copper can lead to oxidative damage including double strand DNA breaks, lipid peroxidation,
and protein oxidation [34]. Although virtually all circulating copper is bound to proteins, namely ceruloplasmin or
serum albumin [38], the concentrations of copper and PAI-1
within several biological compartments are such that physiologically relevant interactions can impact PAI-1 function
[38–41].
This study investigates the molecular basis for copper
effects on PAI-1 stability and overall function. Previous
studies involving surface plasmon resonance with a nickelNTA chip, stopped-flow binding measurements, and HDXMS support a specific metal ion binding site within PAI-1
[24, 29, 33]. Several unanswered questions remain regarding copper effects on PAI-1: Where do copper ion(s) bind
to PAI-1? What is the affinity and stoichiometry of PAI1-copper interactions? How does copper increase PAI-1
stability (i.e., delay PAI-1 latency) when bound to PAI-1
in tandem with VN or the SMB domain? Alternatively,
how does copper binding in the absence of vitronectin
increase the rate of PAI-1 latency conversion? To investigate these questions, we have targeted histidine residues
using site-directed mutagenesis and have compared copper binding and functional effects with wild-type PAI-1.
We have utilized isothermal titration calorimetry (ITC)
and gel-based assays to characterize metal-binding properties. Furthermore, we have used activity measurements
and rates of latency conversion to determine whether the
targeted histidines coordinate copper at a site that leads to
the rapid loss of activity in PAI-1.
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Materials and methods
Protein expression, purification and activity
measurements
Wild-type PAI-1 and variants were cloned in a pET24d
expression plasmid and expressed in Rosetta 2 DE3 pLysS
E. coli cells. PCR-based site-directed mutagenesis was
used to introduce mutations to the triplet codons encoding for histidines 2 and 3 and tryptophan 175 of PAI-1
to create H2A, H3A, H2AH3A, and H2AH3AW175F
PAI-1 variants. Each of the mutations was confirmed by
DNA sequencing. Wild-type PAI-1 and variant constructs
were transformed into the expression cell line, grown,
and expressed using established protocols [24]. A standard three-step purification scheme was employed [24], but
with some notable adjustments for the variants, as follows. Cell lysis and the initial step of ion exchange chromatography were performed at pH 5.5 due to the change
in pI when the N-terminal histidines were absent. This
resulted in improved binding to the sulfopropyl column,
and improved separation within the elutions. In addition,
the N-terminal histidines are required for wild-type PAI-1
binding to an immobilized metal affinity chromatography
column (IMAC). Since variants lacking the histidines
failed to bind to an IMAC column, we used hydrophobic interaction chromatography with separation on a Phenyl Sepharose column instead. PAI-1 was dialyzed into
20 mM K H 2 PO 4 , 600 mM (NH 4 ) 2 SO 4 , 1 mM EDTA,
pH 7 overnight, loaded onto the Phenyl Sepharose column, and eluted with a linear reverse ( NH4)2SO4 gradient (600–10 mM). In the final step of the purification, the
protein was concentrated, and loaded on a size exclusion
chromatography column as previously described [24].
The activity of wild-type and variant forms of PAI-1 was
measured using standard assays [24]. PAI-1 was mixed with
tPA at varying molar ratios ranging from 0.25 to 4 (PAI1:tPA). The inhibitory capacity of PAI-1 was measured in
a gel-based assay, wherein the PAI-1/tPA complex at each
molar ratio was monitored and quantified by densitometry.
PAI-1 inhibition of proteases was also measured in a kinetic
assay in which the tPA-substrate (Spectrozyme tPA, Sekisui
Diagnostics) was added to the mixture containing PAI-1 and
tPA. Cleavage of the p-nitroanaline group of Spectrozyme
tPA was detected by absorbance at 405 nm, allowing for the
measurement of tPA activity over time at each molar ratio
of PAI-1:tPA. Purified active wild-type PAI-1 fully inhibits
tPA with 1.25 molar equivalents of PAI-1. Latent PAI-1 was
generated by dilution in buffer (50 mM sodium phosphate,
300 mM NaCl, 1 mM EDTA, pH 6.25) to a 5 μM concentration, and incubation at 37 °C with light stirring for 6 days.
The aforementioned activity measurements were performed
to confirm that no active PAI-1 remained in the mixture.
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Metal ion titration gel assay
To determine the Cu(II) concentrations required to induce
accelerated PAI-1 latency, we used a gel-based metal ion
titration assay. Serial dilutions of CuSO4 were prepared,
resulting in final Cu(II) concentrations ranging from 5 to
1000 μM. Addition of copper resulted in a drop of as much
as 0.2 pH units, so the solution was readjusted using NaOH.
Incubation with metal was initiated by adding PAI-1 at a
final concentration of 4 μM and maintaining the mixture
at 37 °C in 50 mM MOPS, 100 mM (NH4)2SO4 pH 7.4 for
30 min. After the 30-min incubation, PAI-1 was mixed in
a 1:1 ratio with single-chain tPA (Molecular Innovations).
Three control samples (PAI-1, tPA, and PAI-1/tPA) were
also tested in which copper is not included. Non-reducing
SDS-PAGE dye was added to each sample, followed by boiling for 10 min prior to loading on the gel. The free/latent
PAI-1, free tPA, and PAI-1/tPA complex in each sample
were separated and visualized by SDS-PAGE electrophoresis in a 4–12% gradient gel (Invitrogen). Samples were
subjected to electrophoresis at 150 V for 75 min. SDS-PAGE
gels were stained with Coomassie blue dye overnight, followed by three destaining steps of 90 min in deionized water
containing 30% methanol and 7.5% glacial acetic acid. Gel
pictures were captured using a ChemiDoc XRS molecular
imager (Biorad), and gel band densitometry of the PAI-1/
tPA complex bands was performed using Imagelab (Biorad).
The band intensity of each sample was normalized to 100%
with an untreated PAI-1/tPA complex sample, and to 0%
using the gel background. Averages and error were generated
(n = 2) for each assay, and the normalized band intensities
were plotted as a function of the logarithm of total copper concentration. The midpoint copper concentration for
wild-type PAI-1 or each variant was extrapolated from the
semi-log plots as the copper concentration at which 50% of
PAI-1/tPA complex was observed; this measurement was
used as an expression of relative metal “sensitivity” of the
various forms of PAI-1.
Stability kinetics assays
To measure the half-life of PAI-1 latency conversion, stability assays were performed. PAI-1 at 0.1 μM was incubated
in 50 mM MOPS, 100 mM (NH4)2SO4, 0.1 mM EDTA pH
7.4 at 37 °C. At specific time points, aliquots of PAI-1 were
taken and mixed with 0.1 μM two-chain tPA (Molecular
Innovations), in 50 mM MOPS, 100 mM ( NH4)2SO4, 2 mM
EDTA, 1% bovine serum albumin, pH 7.4. Individual samples were analyzed in 96-well plates by mixing with a final
concentration of 1 mM Spectrozyme tPA substrate (Sekisui
Diagnostics). The reaction was monitored over a 5-min time
period via tPA substrate cleavage at the p-nitroanaline group
that absorbs at 405 nm. This measurement was conducted in
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triplicate for multiple incubation times that covered a range
up to ten times the PAI-1 half-life. The averages of the reaction slopes were entered into GraphPad Prism Software for
analysis. The reaction slopes were plotted as a function of
PAI-1 incubation time to calculate tPA activity over time.
Taking the negative slope and normalizing the data (100%
at t = 0; 0% at the lower baseline time points) yielded the
normalized PAI-1 activity as a function of PAI-1 incubation
time. To determine the rate of latency conversion (klat), the
data were fit to the exponential decay equation xt = x0e−kt,
where xt is the amount of active PAI-1 at a given time, x0 is
the amount of PAI-1 at time 0, k is the rate of latency conversion, and t is time. The half-life of latency conversion was
determined as ln(2) k−1. For assays involving copper, PAI-1
was incubated in the same buffer with 215 μM CuSO4 added.
The buffer was corrected for pH change due to copper addition with NaOH. For assays involving the SMB domain, a
1:2 PAI-1:/SMB complex was formed prior to incubation at
37 °C or copper addition. Controls confirmed that there was
no effect of copper directly on tPA activity [i.e., substrate
cleavage in the presence of copper was the same as in the
absence of metal].
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) was used to determine the thermodynamic parameters associated with Cu(II)
interactions with PAI-1. Active and latent forms of wild-type
and variants of PAI-1 were dialyzed into 100 mM MOPS,
250 mM (NH4)2SO4 at 10 °C for 2 h. Because of the relative instability of the H2AH3A variant of PAI-1, our studies on H2AH3A PAI-1 utilized a variant that contained an
additional mutation, W175F. The W175F switch is a well
characterized substitution used to stabilize the active form
of PAI-1 during purification and to ensure that a significant
amount of latent H2AH3A PAI-1 did not accumulate during
the ITC experiment [42]. Residue 175 is not proximal to the
N terminus and is not involved in metal ion coordination or
its subsequent effects on PAI-1 stability. Copper solutions
were prepared by diluting C
 uSO4 into the matched dialysate
buffer. The copper stock concentration was verified using
atomic absorbance spectroscopy, and the pH corrected to 7.4
at 10 °C using NaOH. Twenty micromolar PAI-1 (2.2 mL
total volume) and copper solution (4 mL) were degassed
under vacuum for 10 min at 5 °C prior to loading into the
(Malvern) MicroCal VP-ITC. The PAI-1 solution was loaded
into the ITC cell (1.394 mL), and the copper solution was
loaded into the ITC syringe. The reference and experimental ITC cells were equilibrated to 10 °C prior to the start
of the experiment. After a preliminary injection of 2 µL,
each additional injection consisted of a 4 µL injection at
120 or 240 s intervals. Experiments were performed at least
in duplicate. Control experiments measuring dilution heats
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were performed in which the copper solution was injected
into buffer. The data were baseline corrected using NITPIC software (University of Texas, Southwestern), and fit to
either a single-site or two-site non-symmetric binding model
in SEDPHAT (National Institutes of Health). The data and
fits were represented using GUSSI software (University of
Texas, Southwestern).

Results
PAI‑1 variants exhibit altered metal sensitivities
The N terminus of PAI-1 comprises a consensus copper
binding motif similar to sites that have been characterized
in serum albumin [43, 44], superoxide dismutase [45], and
prion protein (PrPc) [46, 47]. This motif contains two histidines, H2 and H3, which are thought to be involved in
binding copper. To test for differences in copper binding, we
generated three variants in which the N-terminal histidines
were replaced with alanine residues, denoted as H2A, H3A,
and H2AH3A PAI-1. Whereas wild-type PAI-1 can be purified using an immobilized metal affinity column [24], variants lacking these histidines did not bind to a nickel-charged
metal affinity column, providing direct evidence that these
residues are assessable and can coordinate metal ions.
While this result clearly establishes that a metal-binding
site exists near the N terminus of PAI-1, the key question
is to determine whether copper binding effects the transition between active and latent forms of PAI-1. Initially, a
gel-based copper sensitivity titration assay was developed
to determine the copper concentrations that invoke an accelerated rate of latency conversion on PAI-1. For this assay,
PAI-1 samples were incubated with Cu(II) concentrations
of 5–1000 μM for 30 min, and then mixed with tPA. The
samples were separated by non-reducing SDS-PAGE. After
staining, the band intensities of the PAI-1/tPA complex at
each copper concentration were quantified using gel densitometry. At low concentrations of Cu(II), PAI-1 exhibits robust complex formation with tPA, indicating that it
remains in an active form (Fig. 2a). At intermediate copper
concentrations, there is clearly a mixture of inactive PAI-1
and the PAI-1/tPA complex, and at high metal concentrations, all PAI-1 is latent and no PAI-1/tPA complex is
observed. The data yield a sigmoidal curve in a semi-log
plot, in which the midpoint of the transition represents the
effective concentration of copper that accelerates the latency
transition (Fig. 2b). The midpoint in the curve for wildtype PAI-1 is approximately 150 μM Cu(II) and serves as a
benchmark “sensitivity” for comparison to variants lacking
the hypothesized copper binding residues (Table 1). This
result indicates considerably weaker “sensitivity” in promoting PAI-1 latency compared to the affinity previously
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estimated for copper binding to PAI-1 using stopped-flow
methods (Kd ~90 nM) [33], which presented a discrepancy
that was investigated further.
A variant lacking the putative copper-binding residues
that promote latency would exhibit decreased sensitivity
compared with wild-type PAI-1, and would require higher
Cu(II) concentrations to accelerate PAI-1 latency. Thus, if
copper coordination by the histidine residues accounts for
the accelerated rate of PAI-1 latency, then we predict that
the copper sensitivity of these variants would be decreased.
In contrast, we observed the opposite effect, in which variants lacking the N-terminal histidines are more sensitive to
copper compared with wild-type PAI-1 (Fig. 2b). Each of
the single variants (H2A, H3A) as well as the double variant
(H2AH3A) of PAI-1 required lower Cu(II) concentrations to
induce latency, with midpoints in the sensitivity curves of
approximately 20 μM Cu(II) (Table 1). This unusual observation indicates that the accelerated latency of PAI-1 in the
presence of copper is not due to binding to the N-terminal
histidines. This result also points to the possibility of multiple metal-binding sites with different affinities and different
effects on the latency transition.
A caveat should be noted because these gel titrations are
not equilibrium measurements and the “sensitivities” are not
simple binding constants. Instead, this assay captures points
across a time course with samples that contain a mixture of
free PAI-1 and the PAI-1-copper complex. At the incubation time of 30 min, a mixture of active and latent PAI-1
is present, with copper-bound and copper-free portions
of each form, as determined by the Kd for copper binding
and t1/2 values for latency of PAI-1 and the PAI-1-copper
complex. Because PAI-1-copper complexes may have different half-lives for the latency transition [24], wild-type
and variant forms of PAI-1 can be reliably compared with
this method only when the t1/2 values of the copper-bound
and copper-free species are similar for the wild-type and
engineered forms of PAI-1. Fortunately, because the H2A
and H3A amino acid substitutions did not influence latency
conversion kinetics, we could directly compare the copper
sensitivities among these variants of PAI-1.
SMB domain binding dampens copper sensitivity
of PAI‑1
The SMB domain of VN binds within the flexible joints
region of PAI-1, resulting in a modest stabilization of the
active form [21, 24]. Using the gel-based copper titration
assay, we tested for the effect of SMB binding to PAI-1 on
the copper sensitivity range for accelerated latency. We
expected that the formation of the PAI-1/SMB complex
would lead to decreased copper sensitivity, based on the
stabilizing effects of SMB binding in the absence of copper
ions. Wild-type PAI-1 combined with the SMB domain was
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Fig. 2  Copper titration gel assay for wild-type PAI-1. a Equimolar
mixtures of PAI-1 and tissue-type plasminogen activator (tPA) were
prepared after 30 min incubations of PAI-1 with Cu(II) at a wide
range of concentrations (5–1000 μM, total). Lane 1 contains a molecular ladder, lanes 2–4 are controls in which PAI-1, tPA, and PAI-1/
tPA, respectively, were incubated without Cu(II). Each subsequent
lane contains PAI-1/tPA mixtures incubated with varying Cu(II) concentrations, as indicated. Densitometry of the PAI-1/tPA complex
(series of bands above the 100 kDa band) within the gel was quantified using ImageLab. PAI-1 incubated without copper (100%) (lane
3) and gel background (0%) were used to normalize each data point
as a percentage. b PAI-1/tPA complex formation is plotted as a function of the total Cu(II) concentration. The metric for comparison of

wild-type PAI-1 to PAI-1 variants is taken as the midpoint in copper concentration (“sensitivity”) for which 50% PAI-1/tPA complex
is observed in the densitometry data. Equimolar mixtures of PAI-1
and tPA were prepared after 30 min incubations of PAI-1 with varying Cu(II) concentrations (10–1000 μM, total) in 50 mM MOPS,
100 mM (NH4)2SO4 pH 7.4 at 37 °C. Gel densitometry of the PAI-1/
tPA complex was quantified using ImageLab. The band intensity of
each sample was normalized to 100% with an untreated PAI-1/tPA
complex sample, and to 0% using the gel background. The percent
of PAI-1/tPA complex formation is plotted as a function of the total
Cu(II) concentration. Wild-type and H2AH3A PAI-1 are represented
by inverted triangles and circles, respectively. Experiments were performed in duplicate

Table 1  Copper sensitivities of wild-type and variant forms of PAI-1
determined from gel titration assays

indeed less sensitive to copper, demonstrated by a midpoint
in the gel titration assay of approximately 200 μM Cu(II)
(Fig. 3; Table 1). Prior work has established that the SMB
domain does not interact with copper [29], so the sensitivity measured in this assay is solely due to copper binding to
PAI-1. For comparison, we also tested H2AH3A PAI-1 combined with the SMB domain, and observed a similar copper
sensitivity. While these results represent a modest decrease
in copper sensitivity upon binding of SMB to wild-type PAI1, they reveal a much more significant decrease for H2AH3A
PAI-1. The SMB domain exhibits high affinity binding to
PAI-1 (Kd ~1 nM) [21], and the micromolar concentrations
of proteins used in these assays are well in excess of the Kd.
Although it is possible that there are somewhat different

PAI-1 Variant

Copper
sensitivity,
µM

Wild-type
H2A
H3A
H2AH3A
Wild-type + SMB
H2AH3A + SMB
Wild-type + 250 mM (NH4)2SO4
H2AH3A + 250 nM (NH4)2SO4

150
20
20
20
200
200
>1000
>1000
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Fig. 3  Copper titration comparing wild-type PAI-1 versus H2AH3A
PAI-1. Equimolar mixtures of PAI-1 and tPA were prepared after
30 min incubations of PAI-1 with varying Cu(II) concentrations
(10–1000 μM, total) in 50 mM MOPS, 100 mM (NH4)2SO4 pH 7.4
at 37 °C. Gel densitometry of the PAI-1/tPA complex was quantified
using ImageLab. PAI-1 incubated without copper (100%) and gel
background (0%) were used to normalize each data point as a percentage. The percent of PAI-1/tPA complex formation is plotted as
a function of the total Cu(II) concentration. Wild-type and H2AH3A
PAI-1 are represented by triangles and circles, respectively. Experiments were performed in duplicate

binding affinities for wild-type and H2AH3A PAI-1, the
similar dramatic effects observed in this gel-based assay
indicate that both are fully saturated with SMB under these
conditions. Since binding of the SMB domain alters latency
kinetics independent of copper effects, comparisons with
these data alone are to be taken with caution in this nonequilibrium assay. Nonetheless, it is clear that binding of
the SMB domain to both wild-type PAI-1 and the H2AH3A
variant dampens sensitivity to copper so that differences in
the rate of the latency transition that arise due to the histidine replacements are not observed.
Copper stabilizes the PAI‑1/SMB complex
through binding to the N‑terminal site
To determine how the binding of copper to N-terminal histidines affects the rate of PAI-1 latency, we measured the
latency conversion kinetics of these variants in the presence and absence of copper and the SMB domain (Fig. 4;
Table 2). We first reproduced our previous studies on wildtype PAI-1, but instead used a MOPS buffer system, which
offers the benefit of decreased Cu(II)–buffer interaction
compared with Tris buffer used previously [24]. Wild-type
PAI-1 remains in the active form for a half-life of 70 min in
the MOPS buffer. Ligand binding in MOPS buffer imparts
the same effects on PAI-1 as in Tris buffer; thus wild-type
PAI-1 in the presence of Cu(II) (215 μM) undergoes latency
significantly faster, with a half-life of 20 min. As observed
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Fig. 4  Effects of copper and/or SMB binding on stability kinetics measurements of wild-type and H2AH3A PAI-1. Wild-type
or H2AH3A PAI-1 were incubated at 0.1 μM in 50 mM MOPS,
100 mM (NH4)2SO4, 0.1 mM EDTA, pH 7.4 at 37 °C. Four conditions were tested: PAI-1 alone (white bars), PAI-1 + 215 μM Cu(II)
(black bars), PAI-1 + SMB domain (gray bars), and PAI-1 + SMB
domain + Cu(II) (checkered bars). At various time points, PAI-1 is
mixed with 0.11 μM tPA to react with all PAI-1 remaining in the
active form. tPA activity is measured by addition of 1 mM (final)
Spectrozyme tPA substrate and the absorbance of substrate cleavage
is monitored at A405 for 5 min. PAI-1 inhibitory activity is plotted
versus incubation time and fit to an exponential decay function to
determine the rate of latency transition. Experiments were performed
in triplicate

previously, wild-type PAI-1 is modestly stabilized by incubation with the SMB domain of VN, with a half-life for the
latency conversion of 125 min. In the presence of copper
and the SMB domain, PAI-1 is further stabilized, with a
half-life of 170 min.
Next, we tested the H2AH3A PAI-1 variant under the
same conditions to assess the role of copper binding to these
residues in the PAI-1 latency conversion (Fig. 4; Table 2).
We measured the rate of latency of the H2AH3A variant
alone to determine how the N-terminal histidine substitutions themselves influence the latency transition independent
of copper effects. In these assays, H2AH3A PAI-1 has a halflife of latency conversion of 74 min, which is not statistically
different from wild-type PAI-1, indicating that the introduction of these amino acid substitutions has no intrinsic effect
on the rate of the latency transition in PAI-1. In addition,
H2AH3A PAI-1 is destabilized in the presence of copper,
with a half-life for the latency conversion of 6 min, a shorter
half-life than observed with wild-type PAI-1 bound to copper. This more pronounced rate of acceleration induced by
copper binding to the variant compared to wild-type PAI-1
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Table 2  Kinetic properties for
copper binding to wild-type and
H2AH3A PAI-1

J Biol Inorg Chem (2017) 22:1123–1135
PAI-1 variant

t1/2 for latency t1/2 for latency conconversion, min version [+Cu(II)],
min

t1/2 for latency
t1/2 for latency converconversion (+SMB), sion [+Cu(II), +SMB],
min
min

Active WT
Active H2AH3A

70.7 (±3.6)
72.7 (±5.6)

126.2 (±4.3)
125.0 (±1 10.0)

agrees well with the increased copper sensitivity of the
H2AH3A variant observed in the gel titration assay. This
result clearly indicates that a second metal-binding site
remains in the H2AH3A variant of PAI-1 and suggests that
this additional site is responsible for the accelerated latency
conversion. Furthermore, since the half-life for the latency
transition is actually shorter with the H2AH3A PAI-1 variant, the increased latency differential for this variant relative
to wild-type PAI-1 points to a potential stabilizing role of
copper binding to the N-terminal histidines.
Based on results from the gel titration assay (Fig. 2b),
we hypothesized that copper binding to the N-terminal histidines is the source of the enhanced stabilization observed
when copper is incubated with the PAI-1/SMB complex.
Whereas the copper titration gel assay with the H2AH3A
PAI-1 variant indicated that metal binding to these two histidines was not the interaction that promotes that latency
conversion, the assay with the H2AH3A PAI-1/SMB complex in fact revealed a pronounced decrease in sensitivity
equivalent to that observed with the wild-type PAI-1/SMB
complex. Consistently, latency conversion kinetics indicated
that H2AH3A PAI-1 bound to SMB domain is stabilized
to the same extent as wild-type PAI-1, with a half-life of
latency conversion of 125 min (Fig. 4; Table 2). Interestingly, however, the H2AH3A PAI-1/SMB complex was not
further stabilized compared to wild-type PAI-1 by the binding of copper, with a half-life of latency conversion of only
89 min. This result stands in contrast to observations of the
wild-type PAI-1/SMB complex behavior and supports our
hypothesis, indicating that the enhanced stabilization of the
PAI-1/SMB complex is imparted through copper binding to
the N-terminal histidines of PAI-1. Thus, one of the most
unusual and striking features we observed in our metal studies with PAI-1, i.e., that copper binding concurrently with
the SMB domain yields a highly stable form of PAI-1 that
converts to latency more slowly than with the SMB domain
alone [24, 29, 33], can be attributed to metal coordination
by these N-terminal histidines.
ITC identifies differences in Cu(II) interactions
with active, latent and variant forms of PAI‑1
Isothermal titration calorimetry (ITC) proved to be an
important tool for investigating the thermodynamic characteristics of Cu(II) binding to PAI-1. This method offers
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19.4 (±0.8)
6.2 (±1.0)

170.9 (±2.1)
89.2 (±6.7)

the advantage of providing a full thermodynamic characterization for the interaction, with affinity and stoichiometry
explicitly determined, along with binding enthalpies. In the
ITC experiments, copper was titrated from a stock solution
via small injections into a thermal cell containing PAI-1,
and the power needed to maintain the sample temperature
was measured. To maintain the active form of PAI-1 over
the time course of the experiment, we lowered the experimental temperature to 10 °C, and increased the (NH4)2SO4
concentration to 250 mM. The increased (NH4)2SO4 protects
against non-specific metal ion effects, and was shown in gel
titration assays (Figure 1S) to render PAI-1 relatively insensitive to metal effects on the latency transition. It should be
noted that the PAI-1 latency transition itself results in no
observable heat changes in control ITC experiments [48].
Titrations of active wild-type PAI-1 with Cu(II) ranging up to 650–800 μM were performed and the data were
subject to global fitting analysis. We observed one sharp
transition with an n value of 1.2 in all cases, so the data
were fit to a single-site binding model. Fitting of replicate
data yielded an average Kobs value of 5.4 × 107 M−1 and
ΔHobs = −16.2 kcal mol−1 (Fig. 5a, Figure 2S; Table 3).
This corresponds to an effective Kd = 19 nM, where the
Kd = 1/Kobs, and averages for ΔGobs and −TΔSobs equal to
−10.0 and 5.9 kcal mol−1, respectively. These results agree
well with prior analyses of PAI-1-Cu(II) binding using
stopped-flow kinetics that determined a Kd of ~ 90 nM [33],
and give evidence that copper binding to the active wildtype PAI-1 complex is driven by a highly favorable change
in enthalpy with a slightly unfavorable change in entropy
penalty. By contrast, latent wild-type PAI-1 binds Cu(II)
with two distinct binding transitions, one tight binding transition accompanied by a significantly weaker one. Global fits
to multiple data sets indicated that latent PAI-1 binding of
Cu(II) fits best to a two-site non-symmetric binding model,
yielding average Kobs terms of 2.4 × 107 and 3.4 × 104 M−1,
and ΔHobs terms of −12.0 and −11.2 kcal mol−1 for the
high and low affinity binding sites, respectively (Fig. 5b,
Figure 3S; Table 3). These parameters correspond to average
Kd values of 42 nM and 30 μM for the high and low affinity
sites, respectively. The high affinity Cu(II) binding event in
latent wild-type PAI-1 shows similar free energy to that in
the active PAI-1 described above, although the enthalpic and
entropic contributions are different compared with the site
in the active form. Interestingly, the weaker binding site has
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Fig. 5  Isothermal titration calorimetry of active, latent and variant
forms of PAI-1. Representative isotherms are shown for the titration of a active wild-type PAI-1, b latent wild-type PAI-1, c active
H2AH3A PAI-1, d latent H2AH3A PAI-1 with Cu(II). Isotherms
for the full data set for copper titration into active wild-type PAI1, including global fitting with replicates of four concentrations of
Cu(II) titration solutions, are shown in Figure 2S. Isotherms for the
full data set for copper titration into latent wild-type PAI-1, including
global fitting for replicates of three concentrations of Cu(II) titration
solutions, are shown in Figure 3S. Isotherms for the full data set for

copper titration into active H2AH3A PAI-1, including global fitting
for replicates of two concentrations of Cu(II) titration solutions, are
shown in Figure 4S. Isotherms for the full data set for copper titration into latent H2AH3A PAI-1, including global fitting for replicates
of two concentrations of Cu(II) titration solutions, are shown in Figure 5S. The data are baseline corrected in NITPIC software, and fit to
a one-site binding model in SEDPHAT software. The data and fit are
represented in GUSSI software via heats of injection (kcal mol−1) as
a function of copper/PAI-1 molar ratio. Experiments were performed
in triplicate

a similar ΔHobs term to the high affinity site, yet its −TΔSobs
term is more destabilizing, which effectively weakens the
Cu(II) binding affinity to this site (Table 3). The observed
thermodynamic parameters are a good benchmark for comparison within this study, but further analysis and deconvolution of the data from these complex ion equilibria are
required to identify the origins of these changes.
For comparison, the PAI-1 variant housing the H2AH3A
substitutions was also studied via ITC. As anticipated,
Cu(II) titrations on active and latent forms of H2AH3A
PAI-1 revealed significant differences compared to wildtype PAI-1 binding of copper. Only a single binding event
was observed for both latent and active forms of this variant.
Superficially, this binding event resembles the weak second
binding event observed in the latent wild-type PAI-1. The
thermodynamic parameters extracted from the Cu(II) binding isotherm of the active H2AH3A PAI-1 were an average
Kobs = 3.4 × 104 M−1 and ΔHobs value of −35.8 kcal mol−1
(Fig. 5c, Figure 4S; Table 3). This corresponds to an average

Kd value of 30.5 μM. This value agrees well with the gel
assay result in which the PAI-1 “sensitivity” midpoint value
for the latency conversion was 20 μM (Fig. 2b), which is
similar to the affinity the weak binding site in the latent
wild-type protein. Although we have good faith in the accuracy of the Kobs and ΔGobs terms from this series of ITC
experiments, the ΔHobs term reported here is likely inaccurate [49]. The ΔHobs term is primarily determined from
the first injections of the experiment, and when the affinity
of this binding isotherm is low there is limited curvature in
the isotherm, which leads to an inaccuracy in the measured
enthalpy term. Additional experiments are required to assess
the impact of the ΔHobs for this system. The absence of the
tight binding event within H2AH3A PAI-1 suggests that the
higher-affinity site can be attributed to the N-terminal histidines of PAI-1. The latent H2AH3A PAI-1 exhibits similar
copper binding compared to the active H2AH3A variant.
Latent H2AH3A PAI-1 binds Cu(II) with a single binding
event, with an average Kobs = 6.4 × 104 M−1and ΔHobs value
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Table 3  Thermodynamic properties for Cu(II) binding to wild-type and H2AH3A PAI-1 at 10 °C
PAI-1 variant

Model (n) [Cu(II)]

Kobs, M−1

Kad

Active WT
Active WT
Active WT
Active WT
Latent WT

1
1
1
1
2

7.6 (±3.1) × 108
8.2 (±4.9) × 107
4.8 (±5.5) × 107
4.1 (±2.8) × 107
2.2 (±0.4) × 107

13 (±9) nM −10.2 (±0.3)
19 (±10) nM −10.0 (±0.7)
20 (±20) nM −9.9 (±0.4)
24 (±12) nM −9.8 (±0.2)
46 (±10) nM −9.5 (±0.1)

Latent WT

Active H2AH3A
Active H2AH3A
Latent H2AH3A
Latent H2AH3A
a
b
c
d

2

1
1
1
1

650 µM
700 µM
750 µM
800 µM
650 µM
High affinity
low affinity
750 µM
High affinity
Low affinity
1200 µM
1350 µM
1050 µM
1200 µM

ΔGbobs, (kcal/mol)

ΔHobs, (kcal/mol) −TΔScobs, (kcal/mol)
−15.9 (±0.3)
−16.4 (±0.6)
−15.9 (±1.2)
−16.4 (±0.6)
−12.0 (±2.8)

5.7 (±0.3)
6.3 (±0.7)
5.0 (±1.2)
6.5 (±0.6)
2.5 (±0.1)

4.20 (±2.8) × 104 24 (±12) μM
2.6 (±0.7) × 107 38 (±10) nM

−6.0 (±0.6)
−9.6 (±0.2)

−11.2 (±3.0)
−12.0 (±2.9)

5.1 (±0.6)
2.4 (±0.2)

2.9 (±1.1) × 104
4.2 (±0.9) × 104
2.7 (±2.1) × 104
5.2 (±4.0) × 104
7.7 (±4.6) × 104

−5.8 (±0.4)
−6.0 (±0.1)
−5.7 (±0.4)
−6.1 (±0.6)
−6.3 (±0.4)

−11.2 (±3.1)
−20.0 (±12.0)d
−51.6 (±13.0)d
−37.5 (±11.0)d
−16.4 (±0.6)d

5.4 (±0.2)
14 (±12)d
46 (±13)d
31 (±11)d
10 (±0.4)d

35 (±12) μM
24 (±5) μM
37 (±12) μM
19 (±15) μM
13 (±6) μM

Kd calculated from the following relationship: Kd = 1/Kobs
ΔGobs calculated from ΔGobs = −RT ln Kobs

−TΔSobs term calculated from ΔGobs = ΔHobs − TΔSobs

Parameters measured at the low sensitivity limit of the ITC and likely have significant error associated with them

of −27.0 kcal mol−1 (Fig. 5d, Figure 5S; Table 3). Similar
to the active variant described above, the ΔHobs term for the
latent H2AH3A PAI-1 is likely inaccurate. At this level of
analysis, we consider the copper binding events to active and
latent H2AH3A PAI-1 to be indistinguishable, where they
both yield weak binding events with highly similar binding
constants.

Discussion
Connecting copper binding to PAI‑1 and its functional
stability as an active inhibitor
Hydrogen deuterium exchange measurements showed that
copper binding to PAI-1 increases protein dynamics in
regions relevant to the latency process [29]. PAI-1 lacking
the N-terminal histidines retains the copper effects on protein dynamics, which are localized to the same regions as in
wild-type PAI-1 [29]. This is further evidence that copper
binding to the N-terminal domain cannot be solely responsible for the accelerated latency transition, and that the other
metal-binding site in PAI-1 may be involved in this process.
The goal of this study was to explore the effects that
copper invokes on the stability of active PAI-1 [24, 33] as
observed previously with the metal dependence in rates
of the latency conversion and changes in dynamics [29].
The data collected for the H2AH3A variant of PAI-1 identified the histidine-rich, N-terminal region of PAI-1 to be
involved in copper binding. A comparison of the properties
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of wild-type PAI-1 and the H2AH3A variant (summarized
in Tables 1, 2, 3) establish that H2AH3A PAI-1 is more
sensitive to latency conversion, and indeed converts faster
in the presence of saturating levels of Cu(II) compared with
wild-type PAI-1. Our ITC results demonstrate that there is
a single, high-affinity Cu(II) binding site in active PAI-1 (Kd
19 nM), whereas there are two copper-binding sites in latent
PAI-1 (Kd values were measured to be 40 nM and 40 μM).
Copper binding to the high affinity site in active PAI-1 was
also characterized using stopped-flow kinetics, yielding a
Kd ~90 nM [33] and demonstrating agreement between the
two techniques. On the other hand, the gel-based copper
titrations reveal “sensitivities” in latency conversion that can
be attributed to the second, weaker copper binding site. Substitutions for the N-terminal histidines perturbed the high
affinity copper binding site in active PAI-1, and this variant
protein had an accelerated rate of latency.
Combining these results, we conclude that the high affinity, N-terminal copper binding domain of PAI-1 plays a role
in chelating free Cu(II) in solution, effectively protecting
the active form of the protein, and the low affinity copper
binding site promotes conversion to the latent form of PAI-1.
Upon conversion from the active to the latent form, major
structural changes occur in PAI-1, where two distinctive
metal-binding sites are present. Structural differences in the
latent form involve the insertion of the RCL into the central
β-sheet, which displaces helices D and E in the flexible joint
region and moves them away from the N terminus (Fig. 1).
Based on the heat of Cu(II) coordination, it is likely that the
latent form of PAI-1 contains different c opper−coordinating
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ligands to complement the N-terminal histidines and/or to
comprise the second weaker site. In H2AH3A PAI-1, there
is no high affinity site to bind adventitious Cu(II), which
then leads this variant to sampling conformations more
similar to the latent form which are ultimately highly sensitive to copper. These differences affect the results collected
for wild-type and variant forms of PAI-1 in the gel assays.
Another possibility is that the high salt conditions used for
the ITC experiments may disrupt copper binding to the
weaker metal-binding site in the active protein. This notion
is supported by the gel assays at matching salt concentrations, in which the stability of wild-type or H2AH3A PAI-1
was desensitized to Cu(II) over a broad concentration range
(10 to >1000 μM). While specific disruption of the weaker
metal-binding site is conceivable, the effect of higher ammonium sulfate could also be a more general effect, consistent
with the known effects of ammonium sulfate solutions on
protein stabilization.
Copper coordination by the N‑terminal histidines
stabilizes the PAI‑1/SMB complex
We have reported previously that wild-type PAI-1 in complex with the SMB domain of VN is further stabilized by
copper binding [24]; however, H2AH3A PAI-1 does not
exhibit the synergistic effects of copper and SMB binding.
Thus, it appears that Cu(II) binding to the N-terminal histidines is responsible for the stabilizing effect of metal in
combination with PAI-1 binding by the SMB domain. The
stabilizing effects on PAI-1 that result from binding of the
SMB domain alone are attributed to binding in the flexible
joints region, resulting in widespread restriction of dynamics, especially in nearby helices D, E, and F [28]. Copper
binding to the PAI-1/SMB complex results in a restriction
of dynamics near the N terminus of PAI-1, a phenomenon
that does not occur in the absence of SMB domain [29]. This
restriction of dynamics likely influences a local unfolding
event on the proximal hA that occurs on a time scale relevant
to the latency conversion process [30].

Conclusions
Copper binds to the N-terminal histidines of PAI-1 (H2, H3),
but binding to this site does not result in accelerated latency
in the presence of copper. In fact, binding of copper to this
site stabilizes the active form of PAI-1. We propose that a
second, low-affinity copper binding site is responsible for the
copper-related destabilization of PAI-1. While this second
site remains to be identified, it appears that the different
structures of active and latent PAI-1 allow for alternative
Cu(II) coordination sites. Potential Cu(II) binding residues
near the N-terminal histidines in active PAI-1, including E81
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and H364, will be a focal point of future studies. Whether
the weaker, destabilizing Cu(II)-coordination site represents
an alternative binding mode in active PAI-1 or a distinct,
independent site also must be a focal point of future studies.
While the N-terminal histidines do not constitute the binding
site that promotes the latency transition, this site is valuable
in mediating the striking synergistic effects between copper binding and the SMB domain. Interestingly, histidinerich, N-terminal copper- and nickel-binding domains have
been recently identified in numerous proteins, but a specific
role for these metal-binding motifs is unclear [50–53]. It is
clear, however, that this N-terminal site in PAI-1 is critical
because it appears to stabilize the active conformation of
PAI-1 with SMB present when metal ions would otherwise
quickly render PAI-1 in its latent form, which is ineffective
as an inhibitor.
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